Nanomaterials for Theranostics

Dear Colleagues,

Nanotheranostics, which combine both therapeutic and diagnostic capabilities at a nanoscale, are now perceived as the future of personalized medicine. The techniques involved therein mainly use the nanoparticles’ functionalities that is, biomarking as well as targeted drug delivery based on biomarker distribution. Nanotheranostics is a rapidly growing field, and inorganic materials, such as metal nanoparticles, metal oxide nanoparticles, and quantum dots, are making their mark. Furthermore, hybrid materials such as carbon nanomaterials, degradable polymeric materials, and lipids, in combination with inorganic materials, have also spurred interest in the development of nanotheranostics. A major advantage of inorganic nanoparticles is their enhanced specific surface as well as easy functionalization with targeting organic moieties on surface sites. Hybrid nanotheranostics aim at integrating the functional properties of individual materials through a synergistic effect. In addition, these hybrid materials manifest new functionalities, owing to hybridizing effects making them potential candidates for a combination of imaging and therapy against a plethora of diseases.

This Special Issue will compile publications addressing the main challenges in developing new nanomaterials applied to nanotheranostics. Even though the specificity of nanothernostics limits the nanotoxicity compared with non-specificity treatment options, such as chemotherapy in cancer treatment, the cytotoxicity nevertheless has to be evaluated.  The topics sought after are enumerated as keywords, but are not limited to them. All works describing nanomaterials and new nanotechnologies applied to nanotheranostics are welcome.

Dr. Protima Rauwel
Prof. Dr. habil. Erwan Rauwel
Dr. Hamideh Salehi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Metal nanoparticles
• Metal oxide nanoparticles
• Hybrid nanomaterials (organic–inorganic nanocomposites)
• Quantum dots
• Magnetic nanoparticles
• Drug/gene delivery
• Functionalization of inorganic nanoparticles
• Targeted drug delivery
• Hyperthermia therapy
• Cancer treatment
• Biomarkers
• Nanotoxicity
• Cytotoxicity